1086 related articles for article (PubMed ID: 25517383)
1. Targeting mitochondria metabolism for cancer therapy.
Weinberg SE; Chandel NS
Nat Chem Biol; 2015 Jan; 11(1):9-15. PubMed ID: 25517383
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
3. Restoration of mitochondria function as a target for cancer therapy.
Bhat TA; Kumar S; Chaudhary AK; Yadav N; Chandra D
Drug Discov Today; 2015 May; 20(5):635-43. PubMed ID: 25766095
[TBL] [Abstract][Full Text] [Related]
4. A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Lopez M; Joseph J; Zielonka J; Dwinell MB
Redox Biol; 2018 Apr; 14():316-327. PubMed ID: 29017115
[TBL] [Abstract][Full Text] [Related]
5. Targeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling.
Hagland H; Nikolaisen J; Hodneland LI; Gjertsen BT; Bruserud Ø; Tronstad KJ
Expert Opin Ther Targets; 2007 Aug; 11(8):1055-69. PubMed ID: 17665978
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell metabolism: cancer's Achilles' heel.
Kroemer G; Pouyssegur J
Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
[TBL] [Abstract][Full Text] [Related]
7. Friend or foe? Mitochondria as a pharmacological target in cancer treatment.
Dickerson T; Jauregui CE; Teng Y
Future Med Chem; 2017 Dec; 9(18):2197-2210. PubMed ID: 29182013
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria and Cancer.
Zong WX; Rabinowitz JD; White E
Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
10. The role of compartmentalized signaling pathways in the control of mitochondrial activities in cancer cells.
Rinaldi L; Delle Donne R; Borzacchiello D; Insabato L; Feliciello A
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):293-302. PubMed ID: 29673970
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial substrates in cancer: drivers or passengers?
Kruspig B; Zhivotovsky B; Gogvadze V
Mitochondrion; 2014 Nov; 19 Pt A():8-19. PubMed ID: 25179741
[TBL] [Abstract][Full Text] [Related]
12. Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy.
Dong L; Gopalan V; Holland O; Neuzil J
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114695
[TBL] [Abstract][Full Text] [Related]
13. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
14. Emerging approaches to target tumor metabolism.
Ross SJ; Critchlow SE
Curr Opin Pharmacol; 2014 Aug; 17():22-9. PubMed ID: 25048629
[TBL] [Abstract][Full Text] [Related]
15. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.
Dekhne AS; Hou Z; Gangjee A; Matherly LH
Mol Cancer Ther; 2020 Nov; 19(11):2245-2255. PubMed ID: 32879053
[TBL] [Abstract][Full Text] [Related]
17. The disulfide compound α-lipoic acid and its derivatives: A novel class of anticancer agents targeting mitochondria.
Dörsam B; Fahrer J
Cancer Lett; 2016 Feb; 371(1):12-9. PubMed ID: 26604131
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria in cancer stem cells: a target for therapy.
Loureiro R; Mesquita KA; Oliveira PJ; Vega-Naredo I
Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):102-14. PubMed ID: 23360288
[TBL] [Abstract][Full Text] [Related]
19. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
[TBL] [Abstract][Full Text] [Related]
20. Cancer cell metabolism: Rewiring the mitochondrial hub.
Oliveira GL; Coelho AR; Marques R; Oliveira PJ
Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
